# The Medicines (Products for Human Use) (Fees) Regulations 2016, Paragraph 57A


The fee payable under regulation 19D(1) in connection with the carrying out of a major safety review is—
(a) £61,408, where one or two active ingredients, or combinations of active ingredients, are included in the assessment;
(b) £71,357, where three active ingredients, or combinations of active ingredients, are included in the assessment;
(c) £81,305, where four active ingredients, or combinations of active ingredients, are included in the assessment; or
(d) £91,254, where five or more active ingredients, or combinations of active ingredients, are included in the assessment.

---
Source: https://www.legislation.gov.uk/uksi/2016/190/schedule/2/paragraph/57A (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2016/schedule-2/paragraph-57A
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.